Spain · Venture startup

Who invested in AptaTargets

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2024, from 1 source

Latest round
VentureFeb 2024
Investors
3
See who backed them

The rounds

  1. Feb 2024
    VentureAmount undisclosed

    Source recorded

Founders and team

From AptaTargets's own website: 4 founders, 4 on the team.

David SegarraCo-Founder & CEO
Macarena HernándezCo-Founder & CFO
Mª Eugenia ZarabozoCo-Founder & CFO
Sara SecallCo-Founder & CFO
  • David PiñeiroClinical Operations Manager
  • David SaxnerBusiness Development Director
  • Mads DalsgaardIndependent Board Member
  • Marco PuglieseClinical Operations Manager

Everyone who backed them

EIC AcceleratorGovernment1round
InvereadyVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists AptaTargets as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Criteria Bio VenturesCorporate VCPer its own site

Quick answers about AptaTargets

Who invested in AptaTargets?

AptaTargets's investors include EIC Accelerator, Inveready and Criteria Venture Tech.

How much has AptaTargets raised?

AptaTargets has raised 1 round since 2024, none with a disclosed amount.

When did AptaTargets last raise?

AptaTargets's most recent round was a Venture in Feb 2024.

Who backed AptaTargets first?

AptaTargets's first round on record, in Feb 2024, was backed by EIC Accelerator, Inveready and Criteria Venture Tech.

What stage is AptaTargets at?

AptaTargets's latest named round is a Venture, in Feb 2024.

Where is AptaTargets based?

AptaTargets is based in Spain.

Companies like AptaTargets

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.